• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管钙化中骨相关蛋白的表达及其与冠状动脉钙化积分的血清相关性。

Expression of bone-related proteins in vascular calcification and its serum correlations with coronary artery calcification score.

机构信息

Department of Surgery, University Hospital Rijeka, Rijeka, Croatia.

Department of Radiology, University Hospital Rijeka, Rijeka, Croatia.

出版信息

J Biol Regul Homeost Agents. 2019;33(1):29-38.

PMID:30734547
Abstract

Since vascular calcification is considered a process regulated similar to that of bone tissue mineralization, we investigated the participation of bone formation proteins. We analyzed the correlation of serum circulating bone markers, osteoprotegerin (OPG) and receptor activator of nuclear factor ĸB ligand (RANKL) in chronic kidney disease (CKD) patients, to coronary artery calcification score. We also considered the effect of inorganic phosphate on pro- and anti-calcifying tissue factors. We confirmed that circulating OPG is an independent calcium score predictor with its high serum concentration favoring high coronary artery calcification. In tissue samples of non-diseased human renal arteries, the expression of OPG and receptor activator of nuclear factor ĸB (RANK) was positive, while expression of RANKL was absent. In atherosclerotic specimens and arteries with medial calcification, the most upregulated was expression of bone morphogenetic proteins, BMP-2 and BMP-7, as well as expression of RANK and RANKL. In the diseased arteries, OPG expression was present only in areas where bone structures were formed. In atherosclerotic and medial calcification arteries, loss of alpha-smooth muscle actin (α-SMA) expression was observed. These data suggest a possible regulatory role of the examined proteins, especially OPG and RANKL, in vascular calcification, as well as their possible clinical significance as circulating predictors of vascular calcification.

摘要

由于血管钙化被认为是类似于骨组织矿化的过程受到调节,我们研究了骨形成蛋白的参与。我们分析了血清循环骨标志物、骨保护素 (OPG) 和核因子 κB 受体激活剂配体 (RANKL) 在慢性肾脏病 (CKD) 患者中的相关性,以评估其与冠状动脉钙化评分的关系。我们还考虑了无机磷酸盐对促钙化和抗钙化组织因子的影响。我们证实,循环 OPG 是钙评分的独立预测因子,其高血清浓度有利于冠状动脉钙化。在非病变人类肾动脉的组织样本中,OPG 和核因子 κB 受体激活剂 (RANK) 的表达呈阳性,而 RANKL 的表达则不存在。在动脉粥样硬化标本和中层钙化的动脉中,骨形态发生蛋白 BMP-2 和 BMP-7 以及 RANK 和 RANKL 的表达上调最为明显。在病变的动脉中,仅在形成骨结构的区域观察到 OPG 表达。在动脉粥样硬化和中层钙化的动脉中,观察到α-平滑肌肌动蛋白 (α-SMA)表达的丧失。这些数据表明,所研究的蛋白质,特别是 OPG 和 RANKL,可能在血管钙化中具有调节作用,并且它们作为血管钙化的循环预测因子具有潜在的临床意义。

相似文献

1
Expression of bone-related proteins in vascular calcification and its serum correlations with coronary artery calcification score.血管钙化中骨相关蛋白的表达及其与冠状动脉钙化积分的血清相关性。
J Biol Regul Homeost Agents. 2019;33(1):29-38.
2
RANKL, but Not R-Spondins, Is Involved in Vascular Smooth Muscle Cell Calcification through LGR4 Interaction.骨保护素(RANKL)而非 R- 分泌蛋白(R-Spondins)通过 LGR4 相互作用参与血管平滑肌细胞钙化。
Int J Mol Sci. 2024 May 24;25(11):5735. doi: 10.3390/ijms25115735.
3
[Relationship between coronary and abdominal calcification score, serum osteoprotegerin (OPG), and serum tartrate-resistant acid phosphatase (TRACP) -5b in pre-dialysis CKD patients].[透析前慢性肾脏病患者冠状动脉钙化评分与腹部钙化评分、血清骨保护素(OPG)及血清抗酒石酸酸性磷酸酶(TRACP)-5b之间的关系]
Nihon Jinzo Gakkai Shi. 2010;52(8):1022-8.
4
Relationship between circulating serum osteoprotegerin and total receptor activator of nuclear κ-B ligand levels, triglycerides, and coronary calcification in postmenopausal women.绝经后女性循环血清骨保护素与核因子κB受体活化因子配体总量、甘油三酯及冠状动脉钙化之间的关系。
Menopause. 2014 Jul;21(7):702-10. doi: 10.1097/GME.0000000000000127.
5
Role of osteoprotegerin and its ligands and competing receptors in atherosclerotic calcification.骨保护素及其配体和竞争性受体在动脉粥样硬化钙化中的作用。
J Investig Med. 2006 Nov;54(7):395-401. doi: 10.2310/6650.2006.06019.
6
Does osteoprotegerin or receptor activator of nuclear factor-kappaB ligand mediate the association between bone and coronary artery calcification?骨保护素或核因子-κB受体活化因子配体是否介导了骨骼与冠状动脉钙化之间的关联?
J Clin Endocrinol Metab. 2008 May;93(5):2009-12. doi: 10.1210/jc.2007-2624. Epub 2008 Mar 4.
7
Osteoprotegerin/RANKL axis and progression of coronary artery calcification in hemodialysis patients.骨保护素/RANKL 轴与血液透析患者冠状动脉钙化进展。
Clin J Am Soc Nephrol. 2012 Jun;7(6):965-73. doi: 10.2215/CJN.11191111. Epub 2012 Apr 5.
8
RANKL increases vascular smooth muscle cell calcification through a RANK-BMP4-dependent pathway.核因子κB受体活化因子配体(RANKL)通过RANK-骨形态发生蛋白4(BMP4)依赖的途径增加血管平滑肌细胞钙化。
Circ Res. 2009 May 8;104(9):1041-8. doi: 10.1161/CIRCRESAHA.108.189001. Epub 2009 Mar 26.
9
[Biomarkers of vascular calcifications: the osteoprotegerin/RANK/RANK L axis].
Ann Biol Clin (Paris). 2015 May-Jun;73(3):289-98. doi: 10.1684/abc.2015.1051.
10
Below-knee arterial calcification in type 2 diabetes: association with receptor activator of nuclear factor κB ligand, osteoprotegerin, and neuropathy.2 型糖尿病患者的膝下动脉钙化:与核因子 κB 配体受体激活剂、骨保护素和神经病变的关系。
J Clin Endocrinol Metab. 2014 Nov;99(11):4250-8. doi: 10.1210/jc.2014-1047. Epub 2014 Jul 11.

引用本文的文献

1
Pathophysiology and Clinical Impacts of Chronic Kidney Disease on Coronary Artery Calcification.慢性肾脏病对冠状动脉钙化的病理生理学及临床影响
J Cardiovasc Dev Dis. 2023 May 10;10(5):207. doi: 10.3390/jcdd10050207.
2
Osteoprotegerin/receptor activator of nuclear factor-κB ligand are involved in periodontitis-promoted vascular calcification.骨保护素/核因子κB受体激活剂配体参与牙周炎促进的血管钙化。
Exp Ther Med. 2022 Jun 14;24(2):512. doi: 10.3892/etm.2022.11439. eCollection 2022 Aug.
3
Vascular Calcification-New Insights Into Its Mechanism.
血管钙化——机制的新见解。
Int J Mol Sci. 2020 Apr 13;21(8):2685. doi: 10.3390/ijms21082685.
4
Optimisation of cell and ex vivo culture conditions to study vascular calcification.优化细胞和体外培养条件以研究血管钙化。
PLoS One. 2020 Mar 6;15(3):e0230201. doi: 10.1371/journal.pone.0230201. eCollection 2020.